CLINICAL_TRIALS
trial_result
· 2017-02-13
Clinical Trial Update: TKI 258 in Von Hippel-Lindau Syndrome (VHL) [Phase 2]
Summary
Phase 2 trial of TKI 258 in Von Hippel-Lindau syndrome was terminated, with results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Von Hippel-Lindau Syndrome | Phase 2 | Status: TERMINATED | Results posted: 2017-02-13